ポートフォリオ戦略やディール分析など、開発品の商業化に役立つ情報や市場展望を、独自データでいち早くお届け!

Patient-based analogs for a trusted point of reference

Evaluate AnalogIQ

An advanced analog tool that makes the selection and analysis of analogs simple and accurate.

Transparency Accuracy Efficiency

Evaluate AnalogIQ provides access to the three major regions, multiple therapy areas and over 40 unique filters to ensure complete flexibility for suitable analogue identification.

Forecasting analogs are a key tool in a forecaster’s toolbox, providing the forecaster with valuable insights into the shape of market adoption and peak share for new products.

New starts vs treated patients

With our internal software at the core of the build, development time is reduced by up to 80%. Especially important when complex models are needed quickly, to allow time to effectively prepare for commercial launch of new product lines.

Products and class shares

Benefit from a wider understanding of class share outputs as well as product specific market shares.

Transparency at the core

Further strengthen the credibility of your forecast with a clear & comprehensive overview of the methodology and calculations underpinning the analogue library.

Adaptable uptake

Flexibility within uptake outputs, which then feed directly into your model. Easily share access to the platform and collaborate with colleagues across the business.

Analog Excellence

Unlike other analog tools, it’s unique in that it includes oncology specific variables such as line of therapy, biomarker and patient starts.

Transparent

Data from patient-based forecasts, offering unmatched transparency.

Accurate

Based on patient shares with no need to convert volume shares to patients.

 

Sophisticated

Comprehensive Analogue Library which includes patient, efficacy and safety data.

Advanced

Powerful analysis tools with user-friendly filters to find the precise Analogue you require.

Our oncology-specific Analog Analyzer includes hundreds of separate products, translating to over 2000 reference analogs, covering multiple indications in multiple markets.

Why choose Evaluate AnalogIQ

Transparency at the Core
Further strengthen the credibility of your forecast with a clear & comprehensive overview of the methodology underpinning the analogue library.
Shareable Platform
Easily share access to the platform with colleagues across the business who would also benefit from such an analogue library.
Oncology Specific
Drill down to the specific markets within oncology, analyzing hundreds of analogues based on oncology-specific filters.

Ready to learn more? Contact us today to get started.